









Markets
/
Stocks
/
nasdaq-algn
/

Align Technology Inc

ALGN

131.140USD

-2.000-1.50%

Market hours （ET）Quotes delayed by 15 min

9.51BMarket Cap

21.72P/E TTM



Align Technology Inc

131.140

-2.000-1.50%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Align Technology Inc

Currency: USD Updated: 2025-10-28

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Align Technology Inc's Score

Industry at a Glance

Industry Ranking

46 / 197

Overall Ranking

136 / 4370

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 18 analysts

Buy

Current Rating

176.104

Target Price

+29.82%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Align Technology Inc Highlights

StrengthsRisks

Align Technology, Inc. is a global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad computer-aided design and computer-aided manufacturing (CAD/CAM) software for digital orthodontics and restorative dentistry. The Company provides Align Digital Platform. Its segments include Clear Aligner, and Imaging Systems and CAD/CAM Services (Systems and Services). The Clear Aligner segment consists of comprehensive products, non-comprehensive products and non-case products. Its comprehensive products include Invisalign Comprehensive and Invisalign First. The Company's non-case products include retention products, Invisalign training and adjusting tools. It offers up to four sets of custom clear aligners called Vivera retainers. The Systems and Services segment consists of its iTero intraoral scanning systems. Its services include subscription software, disposables, rentals, leases and pay per scan services.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 4.00B.

Undervalued

The company’s latest PE is 22.46, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 68.48M shares, decreasing 12.43% quarter-over-quarter.

Held by Bruce Richards

Star Investor Bruce Richards holds 191.32K shares of this stock.

Financial Health

Currency: USD Updated: 2025-10-28

The company's current financial score is 8.36, which is higher than the Healthcare Equipment & Supplies industry's average of 7.47. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 1.01B, representing a year-over-year decrease of 1.56%, while its net profit experienced a year-over-year decrease of 29.04%.

Score

Industry at a Glance

Previous score

8.36

Change



Financials

9.31

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

8.03

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

9.44

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

7.70

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.32

Key Metrics

Free cash flow

No Data

Align Technology Inc's Company Valuation

Currency: USD Updated: 2025-10-28

The company’s current valuation score is 7.75, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is 22.46, which is 320.34% below the recent high of 94.41 and 6.20% above the recent low of 21.07.

Score

Industry at a Glance

Previous score

7.75

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 46/197

No Data

Earnings Forecast

Currency: USD Updated: 2025-10-28

The company’s current earnings forecast score is 7.67, which is lower than the Healthcare Equipment & Supplies industry's average of 7.72. The average price target for Align Technology Inc is 171.00, with a high of 224.45 and a low of 140.00.

Score

Industry at a Glance

Previous score

7.67

Change

Support & Resistance

No Data

Analyst Rating

Based on 18 analysts

Buy

Current Rating

176.104

Target Price

+32.27%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

110

Total

Median

Average

Company name

Ratings

Analysts

Align Technology Inc

ALGN

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

Dexcom Inc

DXCM

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-28

The company’s current price momentum score is 6.29, which is lower than the Healthcare Equipment & Supplies industry's average of 6.99. Sideways: Currently, the stock price is trading between the resistance level at 139.46 and the support level at 125.87, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

8.29

Change

-2

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(3)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

1.745

Neutral

RSI(14)

50.008

Neutral

STOCH(KDJ)(9,3,3)

60.458

Sell

ATR(14)

3.897

High Vlolatility

CCI(14)

32.114

Neutral

Williams %R

39.441

Buy

TRIX(12,20)

0.100

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

135.116

Sell

MA10

133.545

Sell

MA20

131.794

Sell

MA50

133.783

Sell

MA100

155.973

Sell

MA200

170.552

Sell

Institutional Confidence

Currency: USD Updated: 2025-10-28

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.49. The latest institutional shareholding proportion is 94.48%, representing a quarter-over-quarter decrease of 7.58%. The largest institutional shareholder is The Vanguard, holding a total of 8.21M shares, representing 11.32% of shares outstanding, with 2.79% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

8.21M

-2.37%

Gund (Gordon Zachary)

4.34M

-0.97%

BlackRock Institutional Trust Company, N.A.

3.35M

-12.93%

State Street Investment Management (US)

2.93M

-2.23%

Ninety One UK Limited

1.92M

-1.10%

Wellington Management Company, LLP

2.17M

+6.63%

T. Rowe Price Investment Management, Inc.

1.84M

+1.03%

Geode Capital Management, L.L.C.

1.78M

-3.89%

Citadel Advisors LLC

1.67M

+3.91%

Capital International Investors

1.62M

Risk Assessment

Currency: USD Updated: 2025-10-28

The company’s current risk assessment score is 4.10, which is lower than the Healthcare Equipment & Supplies industry's average of 4.64. The company's beta value is 1.83. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.